IP Market Updates
April 22, 2016
IN THE NEWS
Study: Lawsuits Down, But Non-Practicing Entities Buying Patents At 'Steady Rate'
The amount of patent-infringement litigation took a noticeable dip in the first quarter of this year compared to the same time period in previous years, (more...)
What should we do about Alice?
On Tuesday morning, April 19, 2016, Manny Schecter, who is IBM's chief patent counsel, gave a keynote presentation at the Innography Insights 2016 (more...)
Apple Settles 2012 Siri Patent Lawsuit for $24.9 Million
Apple will pay a $24.9 million settlement to resolve a 2012 patent infringement lawsuit over the introduction of its Siri voice-activated digital personal (more...)
Patents are no barrier to innovation, despite the myths
The Globe and Mail (subscription)
Robert Barrigar has practised and taught intellectual property law, and written a leading textbook on patent law published by Canada Law Book.
Nanosys, QD Vision Patent Fight Could Shake Up Nanotech Sector
As consumer device makers keep upping the ante with high-definition displays, a patent lawsuit between two well-funded, competing developers of (more...)
Unified Patent Court Means Big Changes for Europe — and the World
Corporate Counsel (registration)
Companies with European patents will have the option of opting out their European patents and patent applications from the Unified Patent Court, (more...)
China leads in world patents for fifth year
China has led the world's patent application list for the fifth year in a row, showcasing its booming culture of innovation, an official said at a meeting on (more...)
The Yahoo Patent Portfolio: What is the market price today?
Business Insider reports that Yahoo's patent portfolio could generate up to $3B. We disagree and we use data to show why. With an estimated street (more...)
Unwired Planet to sell its patents
Non-Practicing Entity (“NPE”) Unwired Planet has announced that it will sell its patent licensing business for $30 million to Dallas-based Optis UP (more...)
Patent Financing: How startups can obtain funding for their patent applications
Year after year the patent laws become more complex. It seems with every decision from the Supreme Court and the Federal Circuit (more...)
Qualcomm Signs 3G/4G Chinese Patent License Agreement with Hisense
SAN DIEGO, April 20, 2016 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that it has signed a new 3G and 4G Chinese Patent License Agreement with Hisense Group Co., Ltd. (Hisense). Under the terms of the agreement, Qualcomm has granted Hisense a royalty-bearing patent license to develop, manufacture and sell 3G WCDMA and CDMA2000 (including (more...)
Pluristem Therapeutics (PSTI) in Licensing Agreement with TES Holdings
Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that it has entered into a licensing agreement with TES Holdings Co., Ltd., a venture company derived from the University of Tokyo, to obtain a key patent in Japan to cover the treatment of ischemic diseases with placental cell therapy rounding out the Company’s IP coverage. This (more...)
Orthophoenix, LLC, Licenses Patents to DFINE, Inc.
LOS ANGELES, CA – 04/20/16 — Marathon Patent Group, Inc. (NASDAQ: MARA) (“Marathon”), a patent licensing company, announced today that its wholly-owned subsidiary, Orthophoenix, LLC, has licensed certain patents to DFINE, Inc. The consideration to be paid by DFINE, Inc. to Orthophoenix and all other commercial terms are confidential. The Orthophoenix portfolio consists of (more...)
Spin Games LLC and Inspired Gaming Sign Licensing Agreement
Spin Games LLC, a leader in the social gaming and interactive gaming technology market, announced today the signing of a licensing agreement that will allow Inspired Gaming’s world leading virtual sports content to be deployed via the Spin RGS (The ROC™) throughout the North American region. Inspired will license to Spin several of their (more...)
Cynapsus and MonoSol Enter Licensing Agreement
Cynapsus Therapeutics and MonoSol Rx announced that they have signed a global licensing agreement for select intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of “off” episodes in patients with Parkinson’s disease (PD).
Sandia National Laboratories Has Licensed ZiBond and DBI Technologies
SAN JOSE, Calif.–Invensas Corporation, a wholly owned subsidiary of Tessera Technologies, Inc. (NASDAQ:TSRA), announced today that Sandia National Laboratories signed a new license agreement for ZiBond® and Direct Bond Interconnect (DBI®) technologies. With this license Sandia will have access to the most advanced 3D integration technologies available, for use in a wide range of semiconductor (more...)
Pieris Pharma (PIRS) Acquires License from Enumeral Biomedical
Pieris Pharma (NASDAQ: PIRS) disclosed that on April 18, 2016, that it and Pieris Pharmaceuticals GmbH, a wholly-owned subsidiary of the Company, entered into a license and transfer agreement with Enumeral Biomedical Holdings, Inc., pursuant to which Pieris acquired a non-exclusive (except in the exclusive field described below) worldwide license to use specified patent (more...)
Qualcomm (QCOM) Enters License Agreement with Yulong
Qualcomm Incorporated (NASDAQ: QCOM) announced that it has signed a new 3G and 4G Chinese patent license agreement with Yulong Computer Telecommunication Scientific (Shenzhen) Co., Ltd. (Yulong), an indirect wholly owned subsidiary of Coolpad Group Limited. Under the terms of the agreement, Qualcomm has granted Yulong a royalty-bearing patent license to develop, manufacture and (more...)
Akari Therapeutics Plc and XL-protein GmbH Sign License Agreement
NEW YORK, LONDON, and FREISING, Germany, April 14, 2016 — Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, and XL-protein, a privately owned biopharmaceutical company, announced today that they have entered into a License, Development and Commercialization Agreement. This partnership is focused on developing a second generation, longer acting version of Coversin.
Rovi Renews License Agreement with Funai
SAN CARLOS, Calif.–Rovi Corporation (NASDAQ: ROVI) today announced that Rovi has renewed its entertainment discovery patent portfolio license agreement with one of the top U.S. TV manufacturers Funai Electric for its entertainment products. This license covers North America and expands upon Funai’s existing agreements with Rovi in Europe and Japan. “Our license agreement with (more...)
Intellia strikes licensing deal with Regeneron
Intellia Therapeutics, one of several companies working to develop CRISPR/Cas 9 technology commercially, on Monday filed to go public in an initially priced $120 million IPO. Concurrently, the biotech announced a collaboration and licensing deal with Regeneron Pharmaceuticals aimed at advancing up to 10 CRISPR-based programs, focusing primarily on liver diseases.
Uponor announces intellectual property agreement with HeatLink Group Inc. and PexCor Manufacturing Inc.
APPLE VALLEY, Minn., April 5, 2016 — Uponor announced today that it has reached an intellectual property licensing agreement with HeatLink Group Inc. and PexCor Manufacturing Inc. HeatLink Group Inc. and PexCor Manufacturing Inc.are affiliated companies based in Calgary, Alberta, that manufacture and sell PEX pipe. The agreement, which allows their use of Uponor’s (more...)